CRENESSITY Trademark
Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for CRENESSITY with the United States Patent and Trademark Office. The USPTO has given the CRENESSITY trademark a serial number of 99021889. The federal status of this trademark filing is PRIORITY ACTION MAILED as of Monday, June 9, 2025. This trademark is owned by Neurocrine Biosciences, Inc.. The CRENESSITY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
General Information
| Serial Number | 99021889 |
| Word Mark | CRENESSITY |
| Filing Date | Wednesday, January 29, 2025 |
| Status | 658 - PRIORITY ACTION MAILED |
| Status Date | Monday, June 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear in dark purple, purple, dark orange, orange from left to right and are positioned above the word CRENESSITY. |
| Goods and Services | Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions |
| Indication of Colors claimed | The color(s) dark purple, purple, dark orange, and orange is/are claimed as a feature of the mark. |
| Goods and Services | Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders |
| Goods and Services | Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 29, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 29, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 29, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
Trademark Events
| Event Date | Event Description |
| Wednesday, January 29, 2025 | NEW APPLICATION ENTERED |
| Wednesday, January 29, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, March 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, March 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, May 22, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 4, 2025 | ASSIGNED TO EXAMINER |
| Thursday, July 10, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Thursday, July 10, 2025 | TEAS AMENDMENT OF USE RECEIVED |
| Monday, June 9, 2025 | PRIORITY ACTION WRITTEN |
| Monday, June 9, 2025 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, June 9, 2025 | PRIORITY ACTION E-MAILED |
